3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
15
Vitamin D Deficiency
13
Prostatic Neoplasms
13
Polycystic Ovary Syndrome
8
Neoplasms
7
Osteoporosis
4
Colorectal Neoplasms
4
Warts
3
Rectal Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Colonic Neoplasms
3
Brain Neoplasms
3
Male Urogenital Diseases
2
Leukemia
2
Cardiovascular Diseases
2
Adenomatous Polyps
2
Stroke
1
Spinal Cord Injuries
1
Skin Neoplasms
1
Seizures
1
Psoriasis
1
Prostate Adenocarcinoma
1
Premature Birth
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Pathologic Processes
1
Pain
1
Osteoarthritis
1
Interventions
pembrolizumab
25
Gemcitabine
21
Nivolumab
17
Cisplatin
17
atezolizumab
14
Carboplatin
11
avelumab
9
vinflunine
7
Ipilimumab
7
Paclitaxel
6
Docetaxel
5
enfortumab vedotin
4
cabazitaxel
4
Pemetrexed
4
Mitomycin
4
cabozantinib
3
Taxes
3
Rogaratinib
3
Magnetic Resonance Spectroscopy
3
Injections
3
Albumin-Bound Paclitaxel
3
tremelimumab
2
sacituzumab govitecan
2
pemigatinib
2
niraparib
2
lenvatinib
2
bempegaldesleukin
2
apatorsen
2
XRP6258
2
Vitamin D
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Transitional Cell
×
Cholecalciferol
×
Clear all
NCT04197089
2022-08-03
VitDURO
Germans Trias i Pujol Hospital
Phase 4
Completed
2 enrolled